FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Novocures Optune Lua for Lung Cancer OKd

Novocure wins PMA approval for Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for treating adult patients with metastatic non-s...

latest-news-card-1
Human Drugs

Court Tosses Novartis Entresto Suit Against FDA

The DC federal court rules in favor of FDA and MSN Pharmaceuticals as defendants in a suit filed by Novartis over the agencys approval of MSNs generic...

latest-news-card-1
Medical Devices

FDA on Curbing X-ray Device Interference

FDA makes recommendations to prevent damage to wearable medical devices from X-ray imaging, including CT scans.

latest-news-card-1
Human Drugs

CGMP Violations at Outin Futures

FDA warns Koreas Outin Futures Corp. about CGMP and misbranding violations at its drug manufacturing facility.

latest-news-card-1
Federal Register

Noxafil Not Withdrawn Over Safety/Efficacy

Federal Register notice: FDA determines that Merck Sharp & Dohmes Noxafil (posaconazole) 100g delayed-release tablets were not withdrawn from sale due...

latest-news-card-1
Federal Register

IntraBio Wins Priority Voucher for Aqneursa Approval

Federal Register notice: FDA issues IntraBio a priority review voucher after determining its recent approval of Aqneursa (levacetylleucine) qualified ...

latest-news-card-1
Human Drugs

14 Observations in Qualgen FDA-483

FDA releases the form FDA-483 with 14 observations issued following an inspection at the Edmond, OK-based Qualgen outsourcing facility.

latest-news-card-1
Medical Devices

FDA Clears AI-Interpreting Echocardiography Software

FDA clears an iCardio.ai 510(k) for its artificial intelligence software EchoMeasure for interpreting echocardiography.

latest-news-card-1
Human Drugs

Jazz Plans sNDA for Zepzelca in Lung Cancer

Jazz Pharmaceuticals plans to file a supplemental NDA next year following positive top-line results from its Phase 3 clinical trial evaluating Zepzelc...

latest-news-card-1
Human Drugs

CDER, CBER Working on START Trial Support Program

CDER director Patrizia Cavazzoni says the Center worked with CBER to launch in 2023 the START program, providing selected participants enhanced commun...